Ashion Analytics
About Ashion Analytics
At Ashion®, we provide personalized options for cancer treatment.Ashion, now part of Genomic Health, Inc., an Exact Sciences Laboratory, is a CAP-accredited and CLIA-certified clinical genomics testing laboratory committed to accelerating the adoption of precision medicine in mainstream oncology, leveraging years of scientific and clinical experience. We offer a wide range of testing capabilities to assist our Physicians, Health Systems, Research and Commercial partners to provide precision cancer treatments.Our newest assay, the GEM ExTra®, covers all DNA-coding regions (whole Exome) and includes full RNA analysis (Transcriptome) of the human genome, providing the most comprehensive genomic assessment available for clinical cancer testing.
Company Metrics
- Employees: 1-10
- Monthly Visits: None
- Tech Stack: None active products
Financial Information
- Estimated Revenue: $1M to $10M
- Total Funding: None None
- Last Funding: None None (None)
- Funding Status: None
Technology Stack
Ashion Analytics actively uses None products in their tech stack.
Market Presence
Industries: Biotechnology, Ruo exome sequencing, Gem extra, Ruo rna sequencing, Biotechnology
Headquarters: Phoenix, Arizona